Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer’s Disease
Manuscript Number:
17-0164R1
Author(s):
Meghan K. Cash, Sultan Darvesh, Drew R. DeBay, Ian R. Macdonald, Selena P. Maxwell, George A. Reid
Disclosures
Meghan K. Cash
Nothing to Disclose
Sultan Darvesh
Equity:
SD is a scientific co-founder and stockholder in Treventis Corporation, a biotech company focused on development of diagnostic and therapeutic agents for Alzheimer’s disease. No other potential conflict of interest relevant to this article